RESUMEN
OBJECTIVES: Adiponectin is a cytokine secreted from adipose tissue that regulates energy homeostasis, inflammation, and cell proliferation. Obesity is associated with increased risk of various cancers, including ovarian cancer. Adipokines, including adiponectin, have been implicated as a factor linking obesity and carcinogenesis. The oncogenic role of adiponectin is not known with regard to various cancer types. We sought to determine the role of adiponectin in angiogenesis in ovarian cancer in vitro. METHODS: We transfected SKOV3 cells with vascular endothelial growth factor small interfering RNA in order to identify the independent angiogenic role of adiponectin in ovarian cancer. The vascular endothelial growth factor knockdown SKOV3 cell lines were treated with adiponectin for 48 h. The cytokines involved in adiponectin-mediated angiogenesis were explored using the human angiogenesis cytokine array and were verified with the enzyme-linked immunosorbent assay. The angiogenic effect of adiponectin was evaluated using the human umbilical vein endothelial cell tube formation assay. We also investigated the effects of adiponectin treatment on the migration and invasion of SKOV3 cells. RESULTS: The number of tubes formed by human umbilical vein endothelial cell decreased significantly after knockdown of vascular endothelial growth factor (via transfection of vascular endothelial growth factor small interfering RNA into SKOV3 cells). When these vascular endothelial growth factor knockdown SKOV3 cells were treated with adiponectin, there was an increase in the number of tubes in a tube formation assay. Following adiponectin treatment, the CXC chemokine ligand 1 secretion increased in a cytokine array. This was confirmed by both enzyme-linked immunosorbent assay and Western blot. The increased secretion of CXC chemokine ligand 1 by adiponectin occurred regardless of vascular endothelial growth factor knockdown. In addition, the induction of migration and invasion of SKOV3 cells were significantly stronger with adiponectin treatment than they were without. CONCLUSION: Adiponectin treatment of ovarian cancer cells induces angiogenesis via CXC chemokine ligand 1 independently of vascular endothelial growth factor. These findings suggest that adiponectin may serve as a novel therapeutic target for ovarian cancer.
Asunto(s)
Adiponectina/genética , Quimiocina CXCL1/genética , Neovascularización Patológica/genética , Neoplasias Ováricas/genética , Adiponectina/metabolismo , Línea Celular Tumoral , Movimiento Celular/genética , Femenino , Células Endoteliales de la Vena Umbilical Humana , Humanos , Invasividad Neoplásica/genética , Neovascularización Patológica/complicaciones , Neovascularización Patológica/patología , Neoplasias Ováricas/complicaciones , Neoplasias Ováricas/patología , ARN Interferente Pequeño/genética , Factor A de Crecimiento Endotelial Vascular/genéticaRESUMEN
Expression of transmembrane 4 superfamily member 5 protein (TM4SF5) was implicated in hepatocellular carcinoma (HCC) and colon cancer. Previously, we have shown that immunization with TM4SF5 peptide-CpG-DNA-liposome complex induces production of TM4SF5-specific antibodies and protects mice from HCC progression in an allograft model. Here, we confirmed expression of TM4SF5 in the mouse colon cancer cell line CT-26 and found that anti-TM4SF5 antibody inhibits growth of CT-26 cells. We then immunized mice with TM4SF5 peptide-CpG-DNA-liposome complex and transplanted CT-26 cells to investigate the vaccination effects. Robust production of TM4SF5-specific antibodies was induced by challenge with CT-26 cells and the tumor growth was significantly suppressed in the immunized mice. The peptide vaccine targeting TM4SF5 consequently showed a prophylactic effect against colon cancer development in a mouse model. These results suggest that the peptide vaccine can be potentially applied in humans to treat colon cancer.
Asunto(s)
Vacunas contra el Cáncer/inmunología , Neoplasias del Colon/inmunología , Proteínas de la Membrana/inmunología , Péptidos/inmunología , Animales , Anticuerpos/inmunología , Anticuerpos/farmacología , Vacunas contra el Cáncer/administración & dosificación , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Colon/metabolismo , Colon/patología , Neoplasias del Colon/mortalidad , Neoplasias del Colon/prevención & control , Modelos Animales de Enfermedad , Citometría de Flujo , Regulación Neoplásica de la Expresión Génica , Humanos , Inmunización , Inmunoglobulina G/inmunología , Inmunoglobulina G/farmacología , Inyecciones Intraperitoneales , Masculino , Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Ratones , Ratones Endogámicos BALB C , Péptidos/administración & dosificación , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Tasa de Supervivencia , Factores de Tiempo , Carga Tumoral/inmunologíaRESUMEN
The specific rates of solvolysis of isobutyl chloroformate (1) are reported at 40.0 °C and those for isobutyl chlorothioformate (2) are reported at 25.0 °C, in a variety of pure and binary aqueous organic mixtures with wide ranging nucleophilicity and ionizing power. For 1, we also report the first-order rate constants determined at different temperatures in pure ethanol (EtOH), methanol (MeOH), 80% EtOH, and in both 97% and 70% 2,2,2-trifluoroethanol (TFE). The enthalpy (ΔH(≠)) and entropy (ΔS(≠)) of activation values obtained from Arrhenius plots for 1 in these five solvents are reported. The specific rates of solvolysis were analyzed using the extended Grunwald-Winstein equation. Results obtained from correlation analysis using this linear free energy relationship (LFER) reinforce our previous suggestion that side-by-side addition-elimination and ionization mechanisms operate, and the relative importance is dependent on the type of chloro- or chlorothioformate substrate and the solvent.
RESUMEN
This study examined the effects of different photoperiod conditions on olive flounder (Paralichthys olivaceus), a commercially important species in Korea. Daily variations in the expression of mRNA for the growth-related genes ary-lalkylamine N-acetyltransferase2 (AANAT2), preprosomatostatin1 (PSS1), and growth hormone (GH) were examined under a 12 h light:12 h dark photoperiod. All the genes were expressed at higher level during the dark period. Melatonin injections increased the expression of GH, but did not significantly affect the expression of PSS. Under short-day conditions (10 h:14 h), the fish gained more weight than under long-day conditions (14 h:10 h). A long nighttime induced melatonin secretion and increased the expression of GH mRNA, promoting weight gain in this species. Therefore, we thought that the long day condition in raising olive flounder may be effective in inducing body growth.
RESUMEN
In order to examine the effects of four different light spectra (white, red, green, and blue) on the oocyte maturation, the change of reproductive parameters, via brain-pituitary-gonad (BPG) axis in grass puffer, were investigated. After exposure four different light spectra for 7 weeks, the abundance of gonadotropin-releasing hormone (GnRH) mRNA which is a type of seabream (sbGnRH) and two different subunit of gonadotropin hormones mRNAs, follicle-stimulating hormone (fshß) mRNA and luteinizing hormone (lhß) mRNA, were analyzed in the brain and pituitary. Histological analysis showed that the mature oocyte ratio in the green spectrum was higher than other light spectra-exposed groups. Gonadosomatic index (GSI) and oocyte developmental stage were also investigated in the gonad based on histological observations. GSI value with the presence of yolk stage oocytes was significantly increased in the green spectrum-exposed group when compared to that of the other light-exposed groups (white, red, and blue) (pË0.05). The abundances of sbGnRH mRNA and fshß mRNA in the green spectrum-exposed group were also significant higher than those of the other light spectra-exposed groups (pË0.05). These results indicate that the maturation of oocyte in grass puffer can be accelerated by exposure to the spectrum of green. To better understand the molecular mechanism for the maturation of oocyte in grass puffer, further study examining the relationship between oocyte development and its related genes is required.
RESUMEN
In several reports, the respiratory syncytial virus (RSV) was identified as an oncolytic virus in cancer cells (e.g., lung and prostate cancer). However, the effects of RSV in hepatocellular carcinoma (HCC) cells have not yet been investigated. Here, we observed the inhibitory effects of RSV infection in HCC cell-lines. Cell growth was significantly decreased by RSV infection in BNL-HCC, Hep3B, Huh-7 and SNU-739 cells. After RSV infection, plaque formation and syncytial formation were observed in affected Hep3B and Huh-7 cells. RSV protein-expression was also detected in Hep3B and Huh-7 cells; however, only Huh-7 cells showed apoptosis after RSV infection. Furthermore, inhibition of cell migration by RSV infection was observed in BNL-HCC, Hep3B, Huh-7 and SNU-739 cells. Therefore, further investigation is required to clarify the molecular mechanism of RSV-mediated inhibition of HCC cell growth, and to develop potential RSV oncolytic viro-therapeutics.
Asunto(s)
Carcinoma Hepatocelular/terapia , Carcinoma Hepatocelular/virología , Neoplasias Hepáticas/terapia , Neoplasias Hepáticas/virología , Viroterapia Oncolítica/métodos , Virus Sincitiales Respiratorios/fisiología , Apoptosis/efectos de los fármacos , Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/patología , Procesos de Crecimiento Celular/fisiología , Línea Celular Tumoral , Humanos , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/patología , Virus Oncolíticos/fisiologíaRESUMEN
Respiratory syncytial virus (RSV) is the major cause of pulmonary inflammation in infants, young children, and immunocompromised adults. However, the RSV vaccine is not yet available commercially. The RSV-F glycoprotein mediates virus-host cell fusion, leading to syncytial formation; therefore, the RSV-F glycoprotein has been a treatment target for prevention and therapy of RSV infection. To produce the RSV-F-protein epitope-specific monoclonal antibody (MAb), BALB/c mice were immunized with a complex consisting of epitope peptide and MB-ODN 4531(O), encapsulated in a phosphatidyl-ß-oleoyl-γ-palmitoyl ethanolamine (DOPE):cholesterol hemisuccinate (CHEMS) complex (Lipoplex(O)). Using conventional hybridoma technology, we obtained two clones able to produce antibodies reactive to two B-cell epitopes of RSV-F protein. Each anti-RSV-F glycoprotein MAb efficiently binds to each epitope. The F7-1A9D10 clone showed specific binding with RSV-F protein. There was no specific protein detected by Western blot analysis using F9 epitope-specific anti-RSV-F glycoprotein MAb (clone F9-1A6C8). However, based on confocal-image analysis, the antibody from the F9-1A6C8 clone showed specific binding with RSV-F protein. It is important that further study on possible applications for passive immunotherapy against RSV infection, such as therapeutic antibody production, is carried out.
Asunto(s)
Adyuvantes Inmunológicos/farmacología , Anticuerpos Monoclonales de Origen Murino/química , Anticuerpos Antivirales/química , ADN Bacteriano/farmacología , Fragmentos de Péptidos/inmunología , Virus Sincitial Respiratorio Humano/inmunología , Animales , Anticuerpos Monoclonales de Origen Murino/biosíntesis , Anticuerpos Monoclonales de Origen Murino/aislamiento & purificación , Anticuerpos Antivirales/biosíntesis , Anticuerpos Antivirales/aislamiento & purificación , Línea Celular Tumoral , Chlorocebus aethiops , Epítopos/inmunología , Femenino , Técnica del Anticuerpo Fluorescente Indirecta , Humanos , Hibridomas , Inmunización , Liposomas , Ratones Endogámicos BALB C , Mycobacterium bovis/genética , Oligodesoxirribonucleótidos/farmacología , Unión Proteica , Células VeroRESUMEN
Weight gain and other metabolic disturbances have now become discouraging, major side effects of atypical antipsychotic drugs (AAPDs). The novel strategies required to counteract these serious consequences, however, should avoid modulating the activities of the neurotransmitter receptors involved because those receptors are the therapeutic targets of AAPDs. Adenosine monophosphate-activated protein kinase is an enzyme that plays a pivotal role in energy homeostasis. We hypothesized that alpha-lipoic acid (ALA), which is known to modulate adenosine monophosphate-activated protein kinase activity in the hypothalamus and peripheral tissues, would ameliorate AAPD-induced weight gain. We describe the case series of a 12-week ALA trial in schizophrenia patients treated with AAPDs. Two of 7 enrolled subjects were dropped from the study because of noncompliance and demand for new medication to treat depressive symptoms, respectively. The mean (SD) weight loss was 3.16 (3.20) kg (P = 0.043, last observation carried forward; median, 3.03 kg; range, 0-8.85 kg). On average, body mass index showed a significant reduction (P = 0.028) over the 12 weeks. During the same period, a statistically significant reduction was also observed in total cholesterol levels (P = 0.042), and there was a weak trend toward the reduction in insulin resistance (homeostasis model assessment of insulin resistance) (P = 0.080). Three subjects reported increased energy subjectively. The total scores on the Brief Psychiatric Rating Scale and the Montgomery-Asberg Depression Rating Scale did not vary significantly during the study. These preliminary data suggest the possibility that ALA can ameliorate the adverse metabolic effects induced by AAPDs. To confirm the benefits of ALA, more extended study is warranted.
Asunto(s)
Antipsicóticos/efectos adversos , Obesidad/tratamiento farmacológico , Esquizofrenia/tratamiento farmacológico , Ácido Tióctico/uso terapéutico , Adulto , Antioxidantes/efectos adversos , Antioxidantes/uso terapéutico , Antipsicóticos/uso terapéutico , Apetito/efectos de los fármacos , Glucemia/metabolismo , Índice de Masa Corporal , Escalas de Valoración Psiquiátrica Breve/estadística & datos numéricos , HDL-Colesterol/sangre , LDL-Colesterol/sangre , Depresión/inducido químicamente , Ayuno/sangre , Ácidos Grasos no Esterificados/sangre , Femenino , Humanos , Insulina/sangre , Resistencia a la Insulina , Masculino , Obesidad/sangre , Obesidad/inducido químicamente , Recurrencia , Ácido Tióctico/efectos adversos , Triglicéridos/sangre , Pérdida de Peso/efectos de los fármacosRESUMEN
The purpose of this study was to evaluate the result of arteriovenous (A-V) grafting with the deep forearm veins as an outflow system in hemodialysis patients. Between June 1999 and July 2001, 27 A-V grafts consisting of ePTFE and deep forearm veins were constructed in 26 patients. All patients followed up for assessment of all relevant values, and the median follow-up period was 17.3 months. Seven grafts (26%) failed during the follow-up. The patency rates were 93% and 80% at 3 months and 12 months, respectively. No difference in patency rate was found between males and females, or between diabetics and nondiabetics. Graft-related complications, excluding graft thrombosis, occurred in five patients. These included operative wound dehiscence in two cases, a graft infection, a seroma, and a mild hypoperfusion in the hand. We conclude that the early patency rate of A-V graft using the forearm deep veins as an outflow system is very good and that this technique may be a recommended surgical modality for vascular access in patients with exhausted superficial veins.